Viewing Study NCT03589950


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-25 @ 9:17 PM
Study NCT ID: NCT03589950
Status: UNKNOWN
Last Update Posted: 2018-07-18
First Post: 2018-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer
Sponsor: The First People's Hospital of Lianyungang
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-08-01
Start Date Type: ESTIMATED
Primary Completion Date: 2020-08-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-08-01
Completion Date Type: ESTIMATED
First Submit Date: 2018-06-22
First Submit QC Date: None
Study First Post Date: 2018-07-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-16
Last Update Post Date: 2018-07-18
Last Update Post Date Type: ACTUAL